实验动物与比较医学 ›› 2026, Vol. 46 ›› Issue (3): 344-356.DOI: 10.12300/j.issn.1674-5817.2025.107

• 人类疾病动物模型 • 上一篇    下一篇

缺血性脑卒中动物模型的中西医整合转化研究进展

潘林琴, 邓向亮()(), 罗云霞()()   

  1. 广东药科大学中医学院, 广州 510006
  • 收稿日期:2025-07-03 修回日期:2025-10-20 出版日期:2026-06-25 发布日期:2026-06-19
  • 通讯作者:
    罗云霞(1991—),女,博士,讲师,硕士生导师,研究方向:中医药防治脑病的临床与基础研究。E-mail:1249728545@qq.com。ORCID:0000-0002-2389-4049
    邓向亮(1985—),男,博士,副教授,硕士生导师,研究方向:中医药基础研究。E-mail: gzy622@163.com。ORCID:0000-0002-7650-0509
  • 作者简介:潘林琴(2000—),女,硕士研究生,研究方向:中药药效评价与应用研究。E-mail:19872719256@163.com
  • 基金资助:
    广东省基础与应用基础研究基金项目“基于TRADD介导的神经元PANoptosis作用探讨当归芍药散治疗缺血性脑中风的机制研究”(2023A1515110725);广东省医学科学技术研究基金项目“基于TNFα/TNFR1信号通路诱导的神经元泛凋亡探讨缺血性脑中风的发病机制”(A2024480);广东省中医药局科研项目“基于TNF-α-TNFR-泛凋亡信号通路探讨白芍活性成分山柰酚治疗缺血性脑中风的分子机制”(20251214);国家自然科学基金-包干制项目“基于肝脾二脏理论从TNFα-TNFR1-PANoptosis信号通路探讨当归芍药散择时治疗缺血性脑中风的机制研究”(82505328)

Advances in Integrative Translational Research on Animal Models of Ischemic Stroke in Traditional Chinese and Western Medicine

PAN Linqin, DENG Xiangliang()(), LUO Yunxia()()   

  1. School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China
  • Received:2025-07-03 Revised:2025-10-20 Published:2026-06-25 Online:2026-06-19
  • Contact: DENG Xiangliang(ORCID: 0000-0002-7650-0509), E-mail: gzy622@163.com
    LUO Yunxia (ORCID: 0000-0002-2389-4049), E-mail: 1249728545@qq.com

摘要:

缺血性脑卒中(ischemic stroke,IS)的病理生理过程极为复杂,现有临床治疗受限于时间窗口狭窄且难以改善残留神经功能障碍。因此,动物模型成为探索该疾病中西医病理机制和评估创新疗法的关键工具。本综述系统梳理了现有的IS造模方法与前沿进展,对比交融西医视域下兴奋性毒性、氧化应激、炎症反应、血脑屏障损伤、铁死亡及泛凋亡等多层次发病机制,以及中医学理论中“风、火(热)、痰、瘀、虚”导致机体气血紊乱与功能失调的核心病机;归纳并对比了局灶性缺血模型、全脑缺血模型和气虚血瘀证等中医病证结合模型的具体造模方法、评价指标与各自应用优劣势。文献回顾提示,结合泛凋亡等新兴细胞死亡机制的探讨,以及在缺血造模基础上叠加环境应激或饮食干预,可以初步筛选和复现IS的特定中医证候,为客观阐释中医药多靶点多通路干预的生物学内涵提供了可行路径。由于传统单一疾病模型难以全面反映临床患者脑网络微环境的复杂性与个体异质性,未来的IS动物模型研究应着眼于中西医发病机制的深度整合,并借助基因编辑技术、高分辨率活体成像、人工智能多组学分析以及脑类器官等多学科交叉技术,构建更贴合临床实际的高仿真多维度模型,从而有效提升缺血性脑卒中创新疗法从基础研究向临床转化的成功率。

关键词: 缺血性脑卒中, 动物模型, 泛凋亡, 中西医结合, 病证结合模型

Abstract:

The pathophysiological process of ischemic stroke (IS) is highly complex. Current clinical treatments are limited by a narrow therapeutic time window and are inadequate for improving residual neurological dysfunction. Therefore, animal models have become essential tools for exploring the pathological mechanisms of this disease from both traditional Chinese medicine (TCM) and Western medicine perspectives,as well as for evaluating innovative therapeutic strategies. This review systematically outlines existing IS modeling methods and cutting-edge advances. It comparatively integrates the multi-layered pathogeneses in Western medicine, including excitotoxicity, oxidative stress, inflammatory responses, blood-brain barrier injury, ferroptosis, and PANoptosis, with the core TCM pathogenesis characterized by disorders of Qi and blood and functional imbalance caused by "wind, fire/heat, phlegm, blood stasis, and deficiency." Furthermore, this paper categorizes and compares the specific modeling techniques, evaluation indicators, and respective advantages and limitations of focal cerebral ischemia models, global cerebral ischemia models, and TCM disease-syndrome combined models, such as the Qi deficiency and blood stasis syndrome. Literature review suggests that, by exploring emerging cell death mechanisms like PANoptosis and introducing environmental stress or dietary interventions on the basis of ischemic modeling, specific TCM syndromes associated with IS can be preliminarily screened out and replicated. It provides a feasible approach for objectively elucidating the biological basis of TCM interventions involving multiple targets and pathways. Given that traditional single-disease models fail to fully capture the complexity and individual heterogeneity of the cerebral network microenvironment in clinical patients, future research on IS animal models should focus on the deep integration of TCM and Western medicine in pathogenesis. By leveraging multidisciplinary technologies, such as gene editing, high-resolution in vivo imaging, artificial intelligence-driven multi-omics analysis, and brain organoids, researchers can construct high-biomimetic, multi-dimensional models that closely mirror clinical scenarios, thereby effectively improving the success rate of translating innovative IS therapies from basic research to clinical application.

Key words: Ischemic stroke, Animal models, PANoptosis, Integrated traditional Chinese and Western medicine, Model of combined disease and syndrome

中图分类号: